-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Late-Breaking Abstracts Session

PhD Trainee
Symposia: Late-Breaking Abstracts Program: Marquee Sessions
Tuesday, December 10, 2024: 7:30 AM-9:00 AM
Hall B (San Diego Convention Center)
Co-chairs:
John Koreth, MD, MBBS, PhD, DPhil, Dana-Farber Cancer Institute, Harvard Medical School and Rakhi P. Naik, MD, Johns Hopkins Hospital
Disclosures:
No relevant conflicts of interest to declare.

This highly anticipated session highlights the Joint Program Committees' selections of the highest-impact abstracts, featuring substantive, novel, and groundbreaking data that were not available by the general abstract submission deadline and would otherwise not be presented at the ASH annual meeting.

Laurie H. Sehn, MD, MPH1, Stefano Luminari2,3, Christian W. Scholz4, Kai Hübel5*, Antonio Salar, MD6*, Shankara Paneesha, MD7,8, Bjorn E Wahlin, MD, PhD9, Panayiotis Panayiotidis, MD10, Hui-Peng Lee, MD11*, Ana Jiménez Ubieto12*, Juan-Manuel Sancho, MD, PhD13*, Tae Min Kim, MD, PhD14*, Eva Domingo Domenech, MD15*, Takahiro Kumode, MD, PhD16*, Christina Poh, MD17, Catherine Thieblemont, MD18, Dries Deeren19*, Edwin de Wit20*, Michael Arbushites21*, Marie-Laure Casadebaig20* and Marek Trneny, MD, CSc22

1BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
2Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy
3Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
4Vivantes Klinikum Am Urban, Berlin, Germany
5University of Cologne and Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
6Hospital del Mar-IMIM, Barcelona, Spain
7University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
8University of Birmingham, Birmingham, United Kingdom
9Karolinska University Hospital, Stockholm, Sweden
10National and Kapodistrian University of Athens Medical School, General Hospital LAIKO, Athens, Greece
11Flinders Medical Centre, Adelaide, Australia
12Servicio de Hematologia, Hospital 12 de Octubre, Madrid, Spain
13ICO-IJC-Hospital Germans Trias i Pujol, Baldona, Universitat Autonoma de Bacrcelona, Barcelona, Spain
14Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
15Institut Català d'Oncologia, Hospital Duran I Reynals, IDIBELL, Barcelona, Spain
16Kindai University, Osaka, Japan
17Fred Hutchinson Cancer Center/ University of Washington, Seattle, WA
18Assistance Publique-Hôpitaux de Paris, Saint-Hospital, Saint-Paris Cité Université, Paris, France
19AZ Delta General Hospital, Roeselare, Belgium
20Incyte International Biosciences, Sarl Morges, Switzerland
21Incyte Corporation, Wilmington, DE
22First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic

Laurent Martin1*, Darko Maric2*, Salam Idriss3,4*, Marine Delamare5,6*, Amandine Le Roy5,7*, Nada Maaziz, PharmD8*, Amandine Caillaud7*, Karim Si-Tayeb7*, Florence Robriquet5,7*, Marion Lenglet5,7*, Lucie Erceau5,7*, Christine Bellanné-Chantelot9*, Isabelle Plo, PhD10*, Bernard Aral, MD, phD11*, Céline Garrec, MD12*, Fabrice Airaud13*, Clara Gianfermi14*, Vincent Antunes2*, Anna Keppner15*, Sarah Mathilda Vincent15*, Alexis Desfontaine16*, Nina Modé17*, Fabien Laporte7*, Anne Gaignerie18*, Caroline Chariau18*, Isabelle Leray18*, Coline Rogue18*, Laurent David19,20*, Richard Redon7*, Stephane Bezieau, MD, phD12*, Lamisse Mansour21,22*, Frederic Galacteros, Prof, MD23,24*, Thibault Maillet25*, Marlène Pasquet, MD26*, Pierre Cougoul27*, Anne-Marie Nloga28*, Claude Gardin, MD, PhD29,30*, Corinne Guitton, MD31*, Viviane Dubruille, MD32*, Vannina Giacobbi-Milet33*, Thierry Leblanc34*, Zuhre Kaya35*, Denis Semama36*, Chloe James, MD, PhD37*, Serge Carillo38*, Marlène Ochmann39*, Anders Waage, MD, PhD40*, Erwan Mortier41,42,43*, Mike Maillasson41,42,43*, Agnès Quéméner41,42*, Holger Cario44,45*, Radek C. Skoda, MD46, Yaël Zermati17,47*, David Hoogewijs2,48*, Alexandre Marchand1*, Francois Girodon, MD, PhD49* and Betty Gardie, PhD50*

1Laboratoire Antidopage Français (LADF), Université Paris-Saclay, Orsay, France
2Section of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, Fribourg, Switzerland
3EPHE, PSL Université, Paris, France, Paris, France
4Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax,, Nantes, France
5EPHE, PSL Université, Paris, France
65 Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax, Nantes, France
7Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax, Nantes, France
8CHU Dijon, Laboratoire de génétique moléculaire et chromosomique, Dijon, FRA
9INSERM UMR1287, Gustave Roussy, Villejuif, France
10INSERM UMR1287, Gustave Roussy, Paris-Saclay University, Villejuif, France
11CHU Dijon, Laboratoire de génétique moléculaire et chromosomique, Dijon, France
12Centre Hospitalier Universitaire De Nantes, Nantes, FRA
13Service de Génétique Médicale, CHU De Nantes, Nantes, FRA
14Laboratoire Antidopage Français (LADF, Université Paris-Saclay, Orsay, France
15SSection of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, Fribourg, Switzerland
16Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, paris, France
17Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, Paris, France
18Nantes Université, CHU Nantes, CNRS, Inserm, BioCore, Nantes, France
19Nantes Université, CHU Nantes, CNRS, Inserm, BioCore,, Nantes, France
20Nantes Université, CHU Nantes, Inserm, CR2TI, Nantes, France
21Département de Biochimie-Biologie Moléculaire, Pharmacologie, Génétique Médicale, and Red Cell Disease Referral Center-UMGGR AP-HP, Hôpitaux Universitaires Henri Mondor, Créteil, France
22Université Paris-Est Créteil, IMRB Equipe Pirenne, Laboratoire d'excellence LABEX GRex,, Créteil, France
23Sickle Cell Referral Center, Henri-Mondor University Hospital- UPEC, AP-HP, Creteil, France
24GHU Henri Mondor, AP-HP, Creteil, France
25Unité de Recherche Clinique, Centre Jospitalier de Macon, Macon, France
26Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France
27Toulouse University Hospital, Toulouse, France
28Hématologie Clinique- Hop. Avicenne AP-HP HUPSSD, Bobigny, France
29Hôpital Avicenne, Hematology Department, AP-HP, Bobigny, France
30UFR SMBH, Sorbonne Paris Nord University, Bobigny, France
31Pediatrics and Sickle Cell Center, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France
32Hematology department, Hôtel Dieu, CHU de Nantes, Nantes, France
33Onco-hématologie pédiatrique, CHU du Mans, Mans, France
34Service d’Hematologie et d’Immunologie Pédiatrique, Centre de Reference Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris and Université Paris Cité, Paris, France
35Pediatric hematology, Gazi University, Ankara, Turkey
36Réanimation néonatale, Service de pédiatrie, CHU Dijon, Dijon, France
37Laboratory of Hematology, Bordeaux University Hospital, Pessac, France
38Service d’hématologie, CHU Orléans, Orléans, France
39Laboratoire de Cytologie Clinique et Cytogénétique, LBMR néoplasies myéloprolifératives, CHU Caremeau, Nîmes, France
40Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, and Research Department, St Olavs Hospital, Trondheim, Norway
41Nantes Université, CNRS, Inserm, CRCI2NA, Nantes, France
42LabEX IGO, Immuno-Onco-Greffe, Nantes, France
43Nantes Université, Centre Hospitalo-Universitaire (CHU) Nantes, Nantes, France
44Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
45Center for Rare Hematopoietic Disorders and Immunodeficiencies (ZSHI Ulm),, Ulm University Medical Center, Ulm, Germany
46Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
47Laboratoire d’Excellence GR-Ex, Paris, France
48National Center of Competence in Research “Kidney.CH”, Zurich, Switzerland
49Laboratory of Biological Hematology, University Hospital of Dijon, Dijon, France
50Ecole Pratique des Hautes Etudes, EPHE, Université de Nantes, CNRS, INSERM,, Nantes, France

Francis Couturaud, MD, PhD1*, Olivier Sanchez2*, Nicolas Meneveau3*, Laurent Bertoletti, MD4*, Gilles Pernod5*, Isabelle Mahe, MD, PhD6, Emilie Presles7*, Philippe Girard8*, Cécile Tromeur9*, Patrick Mismetti10*, Silvy Laporte, MS, PhD11* and Christophe Leroyer12*

1Univ Brest, INSERM U1304-GETBO, CIC INSERM 1412; FCRIN INNOVTE network, CHU de Brest, France
2Université Paris Cité, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, APHP, Paris, France; INSERM UMR_S1140, Innovations Thérapeutiques en Hémostase, Laboratoire de Chirurgie expérimentale, Fondation Alain Carpentier, Paris;, Paris, France
3University Hospital Besançon, 25000 Besançon; FCRIN INNOVTE network, Besançon, France
4CHU De St-Etienne; FCRIN INNOVTE network, St-Etienne, FRA
5University Grenoble Alpes, CNRS/TIMC-IMAG UMR 5525/Themas; FCRIN INNOVTE network, Grenoble, France
6Internal Medicine department, Paris Cité University, Louis Mourier Hospital , APHP, Inserm UMR-S1140, Innovations Thérapeutiques en Hémostase, Paris; F-CRIN INNOVTE Network, France, Colombes, France
7CHU Saint-Etienne; FCRIN INNOVTE network, Saint Etienne, FRA
8Département de Pneumologie, Institut Mutualiste Montsouris, Paris; FCRIN INNOVTE Network, Paris, France
9Univ Brest, INSERM U1304-GETBO, CIC INSERM 1412, CHU Brest; FCRIN INNOVTE network, Brest, France
10Département Thoracique, Institut Mutualiste Montsouris; FCRIN INNOVTE network, Paris, France
11Univ. Jean Monnet, Mines Saint-Etienne, INSERM, U1059, SAINBIOSE, CHU Saint-Etienne; Service de pharmacologie clinique, F-42023, Saint-Etienne; F-CRIN INNOVTE Network, SAINT-ETIENNE, FRA
12Department of Internal Medicine and Chest Diseases; FCRIN INNOVTE network, Brest, FRA

Jihyun Song, PhD, Soo Jin Kim, MS* and Josef T. Prchal, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Françoise Bernaudin, MD1, Suzanne Verlhac, MD2*, Elisabeth Ducros-Miralles3*, Cecile Arnaud, MD4*, Isabelle Genty, MD5*, Marie Petras, MD6*, Catherine Paillard, MD, PHD7*, Thuret Isabelle, MD8*, Annie Kamdem, MD9*, Corinne Pondarré, MD, PHD10*, Giovanna Cannas, MD11*, Christelle Chantalat-Auger, MD12*, Gonzalo De Luna, MD13*, Benoit Meunier, MD14*, Nadia Firah, MD15*, Sophie Pertuisel, MD15*, Corinne Guitton, MD16*, Laure Joseph, MD17*, Florence Missud, MD18*, Claire Pluchart, MD19*, Monique Elmaleh, MD20*, Benedicte Neven, MD, Ph.D21*, Marie Angoso, MD22*, Pierre Frange, MD, PHD23*, Karima Yakouben, MD24*, Bénédicte Bruno, MD25*, Nathalie Dhédin, MD26*, Jean-Hugues Dalle, MD, PHD27, Regis Peffault de Latour, MD, PhD28*, Catherine Belozertseva, MD, PhD29* and Camille Jung, MD, PHD30*

1Referral Center for Sickle Cell Disease/ Clinical Research Department, Hôpital Intercommunal de Créteil, Université Paris-Est, Creteil, France
2Medical Imagery, Robert Debré Paris Hospital, Referral Center For Sickle Cell Disease, Paris, France
3Neuropsychiatry department, Hopital Intercommunal de Créteil, Créteil, France
4Referral Center for Sickle Cell Disease, Hopital Intercommunal de Créteil, Creteil, France
5Referral Center for Sickle Cell Disease, Internal Medicine, Centre Hospitalier Intercommunal de Créteil, Creteil, France
6Referral Center for Sickle Cell Disease, CHU Guadeloupe, Pointe à Pitre, Guadeloupe
7CHRU Hautepierre, Strasbourg, FRA
8Hemato-Pediatrics, la Timone Hospital, CHU, Marseille, France
9Referral Center for Sickle Cell Disease, Intercommunal Creteil Hospital, Creteil, France
10Referral Center For Sickle Cell Disease, University Paris-Est, CréTeil, France
11Hopital Edouard Herriot, Lyon, France
12Department of Internal Medicine, Bicetre Teaching Hospital, AP-HP, Universite Pa, Le Kremlin Bicetre, France
13Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital- UPEC, AP-HP, Creteil, France
14Hemapheresis, Hopitaux Universitaires de Marseille, Marseille, France
15Pediatrics Department, Centre Hospitalier de Pau, Pau, France
16Pediatrics and Sickle Cell Center, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France
17Biotherapy Department, French National Sickle Cell Referral Center, Hopital Necker, AP-HP, Paris, France
18Referral Center For Sickle Cell Disease, Robert Debré Hospital, AP-HP, Paris, France
19Pediatric Oncology, CHU de Reims, Reims, France
20Medical Imagery, Robert Debré Hospital, Paris, France
21BMT unit, Hopital Necker (APHP), Paris, France
22CHU Bordeaux, bordeaux, France
23Necker Hospital, Paris, France
24Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
25Pediatric Hematology Department, Lille University Hospital, Lille, France
26Service d'Hématologie Adolescents et Jeunes Adultes, Hôpital Saint-Louis, PARIS, France
27Hôpital Robert-Debré, GHU APHP Nord Université de Paris Cité, Paris, France
28Hôpital Saint-Louis, Université Paris Cité, Paris, France
29Clinical Research Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France
30Clinical Research Department, CHIC Hospital, Créteil, France

Timothy S. Fenske, MD1, Xin Victoria Wang, PhD2*, Brian G. Till, MD3, Kristie A. Blum, MD4, Matthew Lunning, DO5, Hillard M. Lazarus, MD6, Paul A.S. Fishkin, MD7, Lale Kostakoglu Shields, MD, MPH8*, David W. Scott, MBChB, PhD9, Ann S. LaCasce, MD10, Patrick B. Johnston, MD, PhD11*, Amanda F. Cashen, MD12, Leslie L. Popplewell, MD, MPH13, Robert M. Dean, MD14, Nausheen Ahmed, MD15, Nirav N. Shah, MD16, Nina D. Wagner-Johnston, MD17, Boyu Hu, MD18, Bhagirathbhai R. Dholaria, MBBS19, Richard F. Little, MD, MPH20, Jonathan W. Friedberg, MD21, John P. Leonard, MD22 and Brad S. Kahl, MD12

1Medical College of Wisconsin, Milwaukee, WI
2Dana-Farber Cancer Institute / ECOG-ACRIN Biostatistics, Bostin, MA
3Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
4Emory University / Winship Cancer Institute, Atlanta, GA
5University of Nebraska Medical Center, Omaha, NE
6Case Western Reserve University, Cleveland, OH
7Illinois CancerCare, P.C., Peoria, IL
8NYU Langone Health, New York, NY
9Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
10Dana-Farber Cancer Institute, Boston, MA
11Mayo Clinic, Rochester, MN
12Washington University School of Medicine, Saint Louis, MO
13City of Hope Cancer Treatment Center, Atlanta, GA
14Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute and Case Western Reserve University, Cleveland, OH
15University of Kansas Cancer Center, Kansas City, KS
16Medical College of Wisconsin, Brookfield, WI
17Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
18Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
19Vanderbilt University Medical Center, Nashville, TN
20National Cancer Institute, National Institutes of Health, Washington, DC
21Wilmot Cancer Institute, University of Rochester, Rochester, NY
22Weill Cornell Medicine, New York, NY

See more of: Marquee Sessions